Global Polymerase Chain Reaction Market: Accurate Diagnosis of Life-threatening Diseases to Leverage Global Demand for PCR Kits

In the past few years, advances in the field of molecular diagnostics, especially polymerase chain reaction (PCR) assays, have vastly improved the diagnosis of several life-threatening diseases such as invasive aspergillosis, diphtheria, and a vast number of hematological diseases. The early and accurate diagnosis and treatment of these conditions are essential for effective therapeutic management. In this sense, polymeric chain reaction approaches serve better than other diagnostic techniques and lead to results with acceptable sensitivity and required specificity. As a result, the use of PCR approaches for the effective diagnosis of a variety of diseases has increased in the recent past. This factor is expected to have a notable positive influence on the overall development of the global polymerase chain reaction market.

Download Exclusive PDF Brochure - http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=830

Transparency Market Research estimates that the global polymerase chain reaction market will exhibit a healthy single-digit growth rate over the report’s forecast period and rise to a valuation of US$9,621.0 mn by 2020. In terms of the key applications of polymerase chain reaction systems, the segment of life sciences presently dominates, accounting for a massive chunk in global revenues. Geographically, North America is the most lucrative regional market, accounting for the dominant share in the global polymerase chain reaction market. However, the market in Asia Pacific is estimated to gain traction and emerge as the region with the most significant growth rate over the forecast period.

The global polymerase chain reaction market features a largely consolidated vendor landscape and is dominated few established players, which account for over 50% of the overall market, states Transparency Market Research in a recent publication. Roche Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad, and Becton Dickinson are some of the key vendors in the market. To exploit the growth opportunities for the polymerase chain reaction technology offered globally, companies in the market are focusing on the development of enhanced PCR systems with high specificity, sensitivity, and broad menu of tests. Focus on the development of PCR systems featuring automated workflow, shorter turnaround times, and higher productivity is also a key trend.

Read Report with Complete TOC - http://www.transparencymarketresearch.com/pcr-technologies.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.